PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
The Korean Journal of Internal Medicine10.3904/kjim.2015.30.4.5212015304521Allopurinol hypersensitivity syndrome in patients with hematological malignancies: characteristics and clinical outcomesHong Ki Min, Boin Lee, Seung-Ki Kwok, Ji Hyeon Ju, Wan-Uk Kim, Young Min Park, Sung-Hwan Parkhttp://synapse.koreamed.org/pdf/10.3904/kjim.2015.30.4.521, http://synapse.koreamed.org/DOIx.php?id=10.3904/kjim.2015.30.4.521, http://www.kjim.org/upload/kjim-30-4-_521-530.pdf
Clinical & Experimental Dermatology10.1046/j.1365-2230.1998.00311.x199823132-34Allopurinol hypersensitivity syndrome: hypersensitivity to oxypurinol but not allopurinol HAMANAKA, MIZUTANI, NOUCHI, SHIMIZU, SHIMIZUhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1365-2230.1998.00311.x
Reactions Weekly10.1007/s40278-018-52350-820181722121-21Allopurinolhttp://link.springer.com/content/pdf/10.1007/s40278-018-52350-8.pdf, http://link.springer.com/article/10.1007/s40278-018-52350-8/fulltext.html, http://link.springer.com/content/pdf/10.1007/s40278-018-52350-8.pdf
Reactions Weekly10.1007/s40278-015-7321-520151538117-17Allopurinolhttp://link.springer.com/content/pdf/10.1007/s40278-015-7321-5.pdf, http://link.springer.com/article/10.1007/s40278-015-7321-5/fulltext.html, http://link.springer.com/content/pdf/10.1007/s40278-015-7321-5
Reactions Weekly10.1007/s40278-015-3952-920151563123-23Allopurinolhttp://link.springer.com/content/pdf/10.1007/s40278-015-3952-9.pdf, http://link.springer.com/article/10.1007/s40278-015-3952-9/fulltext.html, http://link.springer.com/content/pdf/10.1007/s40278-015-3952-9
Reactions Weekly10.1007/s40278-013-7697-z2013148217-7Allopurinol/hydrochlorothiazide/triamterene interactionhttp://link.springer.com/content/pdf/10.1007/s40278-013-7697-z.pdf, http://link.springer.com/article/10.1007/s40278-013-7697-z/fulltext.html, http://link.springer.com/content/pdf/10.1007/s40278-013-7697-z
Reactions Weekly10.1007/s40278-014-8612-y2014148716-6Allopurinolhttp://link.springer.com/content/pdf/10.1007/s40278-014-8612-y.pdf, http://link.springer.com/article/10.1007/s40278-014-8612-y/fulltext.html, http://link.springer.com/content/pdf/10.1007/s40278-014-8612-y
Reactions Weekly10.1007/s40278-014-9667-52014149416-6Allopurinolhttp://link.springer.com/content/pdf/10.1007/s40278-014-9667-5.pdf, http://link.springer.com/article/10.1007/s40278-014-9667-5/fulltext.html, http://link.springer.com/content/pdf/10.1007/s40278-014-9667-5
PharmacoEconomics & Outcomes News10.1007/s40274-013-0051-0201366915-5Cost effective approaches to prevent allopurinol hypersensitivityhttp://link.springer.com/content/pdf/10.1007/s40274-013-0051-0.pdf, http://link.springer.com/article/10.1007/s40274-013-0051-0/fulltext.html, http://link.springer.com/content/pdf/10.1007/s40274-013-0051-0
Reactions Weekly10.1007/s40278-016-21573-120161621120-20Allopurinol/antitubercular drugshttp://link.springer.com/content/pdf/10.1007/s40278-016-21573-1.pdf, http://link.springer.com/article/10.1007/s40278-016-21573-1/fulltext.html, http://link.springer.com/content/pdf/10.1007/s40278-016-21573-1.pdf